IPSEF
Price
$113.13
Change
+$9.63 (+9.30%)
Updated
Jun 9 closing price
Capitalization
13.43B
Intraday BUY SELL Signals
TEVJF
Price
$20.01
Change
+$5.69 (+39.73%)
Updated
Sep 25 closing price
Capitalization
40.08B
Intraday BUY SELL Signals
Interact to see
Advertisement

IPSEF vs TEVJF

Header iconIPSEF vs TEVJF Comparison
Open Charts IPSEF vs TEVJFBanner chart's image
Ipsen S.A
Price$113.13
Change+$9.63 (+9.30%)
Volume$150
Capitalization13.43B
Teva Pharmaceutical Industries
Price$20.01
Change+$5.69 (+39.73%)
Volume$100
Capitalization40.08B
IPSEF vs TEVJF Comparison Chart in %
TEVJF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IPSEF vs. TEVJF commentary
Feb 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSEF is a Hold and TEVJF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 03, 2026
Stock price -- (IPSEF: $113.13 vs. TEVJF: $28.36)
Brand notoriety: IPSEF and TEVJF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IPSEF: 100% vs. TEVJF: 48%
Market capitalization -- IPSEF: $13.43B vs. TEVJF: $40.08B
IPSEF [@Pharmaceuticals: Generic] is valued at $13.43B. TEVJF’s [@Pharmaceuticals: Generic] market capitalization is $40.08B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.68B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.72B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSEF’s FA Score shows that 2 FA rating(s) are green whileTEVJF’s FA Score has 1 green FA rating(s).

  • IPSEF’s FA Score: 2 green, 3 red.
  • TEVJF’s FA Score: 1 green, 4 red.
According to our system of comparison, both IPSEF and TEVJF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TEVJF’s TA Score shows that 2 TA indicator(s) are bullish.

  • TEVJF’s TA Score: 2 bullish, 3 bearish.

Price Growth

IPSEF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while TEVJF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +22.34%. For the same industry, the average monthly price growth was +1.29%, and the average quarterly price growth was +17.01%.

Industries' Descriptions

@Pharmaceuticals: Generic (+22.34% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TEVJF($40.1B) has a higher market cap than IPSEF($13.4B). TEVJF has higher P/E ratio than IPSEF: TEVJF (23.44) vs IPSEF (18.07). IPSEF YTD gains are higher at: 0.000 vs. TEVJF (-0.874). TEVJF has higher annual earnings (EBITDA): 2.84B vs. IPSEF (1.3B). TEVJF has more cash in the bank: 2.2B vs. IPSEF (1.45B). IPSEF has less debt than TEVJF: IPSEF (869M) vs TEVJF (17.1B). TEVJF has higher revenues than IPSEF: TEVJF (16.8B) vs IPSEF (3.76B).
IPSEFTEVJFIPSEF / TEVJF
Capitalization13.4B40.1B33%
EBITDA1.3B2.84B46%
Gain YTD0.000-0.874-
P/E Ratio18.0723.4477%
Revenue3.76B16.8B22%
Total Cash1.45B2.2B66%
Total Debt869M17.1B5%
FUNDAMENTALS RATINGS
IPSEF vs TEVJF: Fundamental Ratings
IPSEF
TEVJF
OUTLOOK RATING
1..100
4697
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
7523
SMR RATING
1..100
8967
PRICE GROWTH RATING
1..100
7239
P/E GROWTH RATING
1..100
2276
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IPSEF's Valuation (26) in the null industry is somewhat better than the same rating for TEVJF (77). This means that IPSEF’s stock grew somewhat faster than TEVJF’s over the last 12 months.

TEVJF's Profit vs Risk Rating (23) in the null industry is somewhat better than the same rating for IPSEF (75). This means that TEVJF’s stock grew somewhat faster than IPSEF’s over the last 12 months.

TEVJF's SMR Rating (67) in the null industry is in the same range as IPSEF (89). This means that TEVJF’s stock grew similarly to IPSEF’s over the last 12 months.

TEVJF's Price Growth Rating (39) in the null industry is somewhat better than the same rating for IPSEF (72). This means that TEVJF’s stock grew somewhat faster than IPSEF’s over the last 12 months.

IPSEF's P/E Growth Rating (22) in the null industry is somewhat better than the same rating for TEVJF (76). This means that IPSEF’s stock grew somewhat faster than TEVJF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IPSEFTEVJF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
46%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
48%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
17%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
13%
Bearish Trend 2 days ago
43%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
TEVJF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SKYY119.300.17
+0.14%
First Trust Cloud Computing ETF
GBLD18.32-0.05
-0.29%
Invesco MSCI Green Building ETF
JPEM64.42-0.21
-0.32%
JPMorgan Diversified Return EMkts Eq ETF
MINV37.70-0.14
-0.37%
Matthews Asia Innovators Active ETF
IYRI48.81-0.50
-1.01%
NEOS Real Estate High Income ETF

IPSEF and

Correlation & Price change

A.I.dvisor tells us that IPSEF and TEVJF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPSEF and TEVJF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSEF
1D Price
Change %
IPSEF100%
N/A
TEVJF - IPSEF
24%
Poorly correlated
N/A
IPSEY - IPSEF
6%
Poorly correlated
-1.28%
JUSHF - IPSEF
6%
Poorly correlated
N/A
INDV - IPSEF
5%
Poorly correlated
-1.07%
INIS - IPSEF
2%
Poorly correlated
+4.14%
More

TEVJF and

Correlation & Price change

A.I.dvisor tells us that TEVJF and IPSEF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TEVJF and IPSEF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVJF
1D Price
Change %
TEVJF100%
N/A
IPSEF - TEVJF
24%
Poorly correlated
N/A
TKPHF - TEVJF
17%
Poorly correlated
N/A
ROMJF - TEVJF
4%
Poorly correlated
-0.35%
VTRS - TEVJF
3%
Poorly correlated
+4.51%
SGIOF - TEVJF
1%
Poorly correlated
N/A
More